Shanghao Liu

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD).

Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD).

Journal: Communications medicine

Published: March 06, 2025

Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Population-Based Cohort Study.

Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Population-Based Cohort Study.

Journal: Alimentary pharmacology & therapeutics

Published: January 07, 2025

Post-TIPS Overt Hepatic Encephalopathy Increases Long-Term but Not Short-Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large-Scale, Multicenter Real-World Study.

Post-TIPS Overt Hepatic Encephalopathy Increases Long-Term but Not Short-Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large-Scale, Multicenter Real-World Study.

Journal: Alimentary pharmacology & therapeutics

Published: November 06, 2024

Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on "Epidemiology of metabolic dysfunction-associated steatotic liver disease".

Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on "Epidemiology of metabolic dysfunction-associated steatotic liver disease".

Journal: Clinical and molecular hepatology

Published: October 17, 2024

DiabetesLiver score: A non-invasive algorithm for advanced liver fibrosis and liver-related outcomes in type 2 diabetes mellitus population.

DiabetesLiver score: A non-invasive algorithm for advanced liver fibrosis and liver-related outcomes in type 2 diabetes mellitus population.

Journal: Med (New York, N.Y.)

Published: October 16, 2024

Fibrosis-4plus score: a novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): an international multicenter study.

Fibrosis-4plus score: a novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): an international multicenter study.

Journal: Clinical and molecular hepatology

Published: October 10, 2024

High prevalence of steatotic liver disease and fibrosis in the general population: A large prospective study in China.

High prevalence of steatotic liver disease and fibrosis in the general population: A large prospective study in China.

Journal: Journal of hepatology

Published: July 16, 2024

Baseline and Dynamic MAF-5 Score to Predict Liver Fibrosis and Liver-Related Events in General Population With MASLD.

Baseline and Dynamic MAF-5 Score to Predict Liver Fibrosis and Liver-Related Events in General Population With MASLD.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: May 16, 2024

LiverRisk score: An accurate, cost-effective tool to predict fibrosis, liver-related, and diabetes-related mortality in the general population.

LiverRisk score: An accurate, cost-effective tool to predict fibrosis, liver-related, and diabetes-related mortality in the general population.

Journal: Med (New York, N.Y.)

Published: November 06, 2023

Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study.

Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study.

Journal: MedComm

Published: October 18, 2023

Corrigendum: Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: a multicenter study.

Corrigendum: Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: a multicenter study.

Journal: Frontiers in oncology

Published: August 16, 2023

Erratum for: Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.

Erratum for: Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.

Journal: Radiology

Published: July 25, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026